课题基金 / 基金详情

EFFECT OF PIOGLITAZONE TREATMENT ON THE PROGRESSION OF IMPAIRED GLUSCOSE TOLERAN

EFFECT OF PIOGLITAZONE TREATMENT ON THE PROGRESSION OF IMPAIRED GLUSCOSE TOLERAN
吡格列酮治疗对葡萄糖耐量受损进展的影响
批准号:
7376140
负责人:
Stephen colgan Clement
金额:
$22.1万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-12-01 至 2006-11-30

项目摘要

项目成果

Stephen colgan Clement的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. This study is an examination of whether treatment of individuals with impaired glucose tolerance with pioglitazone can prevent or delay the development of type 2 diabetes mellitus.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
EFFECT OF PIOGLITAZONE TREATMENT ON THE PROGRESSION OF IMPAIRED GLUSCOSE TOLERAN
  • 批准号:
    7951973
  • 项目类别:
  • 资助金额:
    $12.09万
  • 财政年份:
    2009
  • 负责人:
    Stephen colgan Clement
  • 依托单位:
LANTUS VS STANDARD CARE VS PLACEBO IN IFG, IGT AND EARLY TYPE II DIABETES MELLIT
  • 批准号:
    7951972
  • 项目类别:
  • 资助金额:
    $2.68万
  • 财政年份:
    2009
  • 负责人:
    Stephen colgan Clement
  • 依托单位:
2X2 FACTORIAL DESIGN STUDY TO EVALUATE THE EFFECTS OF LANTUS< (INSULIN GLARGINE)
  • 批准号:
    7719034
  • 项目类别:
  • 资助金额:
    $3.35万
  • 财政年份:
    2008
  • 负责人:
    Stephen colgan Clement
  • 依托单位:
EFFECT OF PIOGLITAZONE TREATMENT ON THE PROGRESSION OF IMPAIRED GLUSCOSE TOLERAN
  • 批准号:
    7719036
  • 项目类别:
  • 资助金额:
    $17.55万
  • 财政年份:
    2008
  • 负责人:
    Stephen colgan Clement
  • 依托单位:
海外基金